NR1H4 and cholangiocarcinoma: In addition, farnesoid X receptor (FXR), which is downregulated in intrahepatic-cholangiocarcinoma cell lines and human samples, has a negative correlation with aggressiveness and poor prognosis of patients with intrahepatic-cholangiocarcinoma.